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For asthma and psychological morbidity, it is well established that higher prevalence among males in
childhood is replaced by higher prevalence among females by adolescence. This review investigates
whether there is evidence for a similar emerging female ‘excess’ in relation to a broad range of physical
morbidity measures. Establishing whether this pattern is generalised or health outcome-speciﬁc will
further understandings of the aetiology of gender differences in health. Databases (Medline; Embase;
CINAHL; PsycINFO; ERIC) were searched for English language studies (published 1992e2010) presenting
physical morbidity prevalence data for males and females, for at least two age-bands within the age-
range 4e17 years. A three-stage screening process (initial sifting; detailed inspection; extraction of full
papers), was followed by study quality appraisals. Of 11 245 identiﬁed studies, 41 met the inclusion
criteria. Most (n ¼ 31) presented self-report survey data (ﬁve longitudinal, 26 cross-sectional); 10 pre-
sented routinely collected data (GP/hospital statistics). Extracted data, supplemented by additional data
obtained from authors of the included studies, were used to calculate odds ratios of a female excess, or
female:male incident rate ratios as appropriate. To test whether these changed with age, the values were
logged and regressed on age in random effects meta-regressions. These showed strongest evidence of an
emerging/increasing female excess for self-reported measures of headache, abdominal pain, tiredness,
migraine and self-assessed health. Type 1 diabetes and epilepsy, based on routinely collected data, did
not show a signiﬁcant emerging/increasing female excess. For most physical morbidity measures
reviewed, the evidence broadly points towards an emerging/increasing female excess during the tran-
sition to adolescence, although results varied by morbidity measure and study design, and suggest that
this may occur at a younger age than previously thought.
 2012 Elsevier Ltd. All rights reserved.Introduction
It is well established that higher rates of psychological
morbidity among males in childhood are replaced by higher
female rates in adolescence and adulthood (Bennett, Ambrosini,
Kudes, Metz, & Rabinovich, 2005; Cohen et al., 1993;
Cyranowski, Frank, Young, & Shear, 2000; Ge, Conger, & Elder,
2001; Hankin & Abramson, 1999; Marcotte, Fortin, Potvin, &
Papillon, 2002; Nolen-Hoeksema & Girgus, 1994; Petersen,
Sarigiani, & Kennedy, 1991; Schraedley, Gotlib, & Hayward, 1999;
Shibley Hyde, Mezulis, & Abramson, 2008). This pattern has also
been reported for asthma prevalence (Almqvist, Worm, &ax: þ44 (0)1413372389.
n).
All rights reserved.Leynaert, 2008; Nicolai, Pereszlenyiova-Bliznakova, Illi, Rein-
hardt, & von Mutius, 2003; Postma, 2007; Sears et al., 2003; Venn,
Lewis, Cooper, Hill, & Britton, 1998; Zannolli & Morgese, 1997).
This paper examines whether there is evidence of an emerging or
increasing female ‘excess’ in relation to other forms of physical
morbidity. Identifying and appraising evidence for this pattern,
particularly assessing whether it is general or speciﬁc to certain
symptoms or conditions, is important, since it may enhance
understanding of the apparent deterioration in some aspects of
female health which begins in adolescence and continues into
adulthood, and hence indicate potential ways to ameliorate
gender differentials.
In the early 1990s, Sweeting (1995) conducted a narrative
review of research on physical health (longstanding illness and the
speciﬁc conditions asthma, diabetes mellitus, migraine and other
headaches), psychological well-being and health service utilisation
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distribution of ill-health during the transition from childhood to
adolescence. Since then, this pattern has been widely reported,
particularly in respect of psychological morbidity, and has even
been described as a central feature of adolescent health in ‘a large
proportion of the world’s industrialised countries’ (Torsheim et al.,
2006, p. 823). Attempts to explain these patterns have concentrated
on psychological morbidity (Cyranowski et al., 2000; Nolen-
Hoeksema & Girgus, 1994; Rutter, Caspi, & Mofﬁtt, 2003) and
have advanced similar explanations to those put forward for gender
differences in adult health, such as different roles, stresses, expec-
tations, reporting behaviours, lifestyles, as well as genetic and
biological differences.
Examples of factors which might explain the ‘gender reversal’ in
health beginning in early adolescence include puberty, which is
associated with hormonal changes and alterations in body shape
generally regarded as more positive for males (Eme, 1979; Polce-
Lynch, Myers, Kilmartin, Forsmann-Falck, & Kliewer, 1998) and
also with physical symptoms or conditions such as menstrual
cramps (Harlow & Park, 1996), headaches and migraine (Deubner,
1977) in females. Another possible explanation is societal gender
expectations (for females to be academically successful, hard-
working and attractive, for males to be strong and stoic), which
become more differentiated during this life stage (MacLean,
Sweeting, & Hunt, 2010; West & Sweeting, 2003), potentially
leading to differences in the experience of psychosocial stressors
and impacting on illness behaviours such as symptom reporting.
Gender differences in lifestyle, for example higher levels of physical
activity in adolescent males (Coleman & Schoﬁeld, 2001), might
also contribute to gender differences in adolescent health. The
relatively few studies which have speciﬁcally examined, or
attempted to account for the gender reversal in relation to physical
morbidity (Angold, Costello, Erkanli, & Worthman, 1999; Eminson,
Benjamin, Shortall, Woods, & Faragher, 1996; Haugland, Wold,
Stevenson, Aaroe, & Woynarowska, 2001; MacLean et al., 2010;
Sweeting, West, & Der, 2007) have considered such explanations,
but fully accounting for these patterns has proved difﬁcult. In
addition, a cross-national study of 11e15-year olds from a range of
European and North American countries found that the size of
gender differences in adolescent health varied between-countries
and was associated with each country’s male:female life expec-
tancy ratio, suggesting that macro-social contextual factors might
also impact on gender differences in adolescent health (Torsheim
et al., 2006).
Contrasting with the research focus on an emerging or
increasing female excess in psychological distress, no reviews have,
to our knowledge, been conducted with the aim of systematically
investigating the extent to which there is evidence of an emerging
or increasing female excess in relation to a range of physical
morbidity measures. There are a number of reasons for conducting
such a review. Firstly, it should enable the synthesis and appraisal
of evidence in relation to changing gender differences in health
between childhood and adolescence in physical morbidity and, in
turn, allow a judgement about the robustness of evidence for an
emerging/increasing female excess. Secondly, it should shed light
onwhether this pattern is found for physical morbidity generally or
is speciﬁc to certain symptoms or conditions. Thirdly, it could
highlight new areas for investigation to further understandings of
the aetiology of gender differences in health. Fourthly, it should
ensure that future primary research in this area avoids replication
and is informed by the ‘best available evidence’ (Bambra, 2011) of
the gender-by-age patterning of physical morbidity during child-
hood and adolescence. Finally, it may inform strategies and inter-
ventions that aim to prevent or reduce gender inequalities in
health.The identiﬁcation of ‘reversals of fortune’ within Sweeting’s
(1995) earlier review might suggest a simple switch from excess
male morbidity in childhood to excess female morbidity by mid
adolescence. In attempting to conceptualise patterns of gender-by-
age differences in morbidity more critically and comprehensively
for this review, we represented diagrammatically a series of plau-
sible patterns. These are described below and shown in Fig. 1.
Diagrams in the left-hand column schematically represent possible
male and female morbidity rates from mid-late childhood to mid
adolescence, whilst those in the right-hand column represent the
associated odds of female excess morbidity over the same life stage.
‘Type 1 reversals’ represent variations on an emerging or
increasing female excess. They can originate from: a) a male excess
reversing to a female excess (via increasing female rates with age
accompanied by decreasing male rates, stable male rates or male
rates which increase with age, but less steeply than those of
females); b) decreasing male rates with age while female rates
remain stable or decrease less steeply; c) an emerging female
excess from a point of no gender difference; d) an existing small
female excess at younger ages which increases with age. In respect
of these patterns the odds of morbidity among females compared
to males would start from below (‘Types 1a’ and ‘1b’), at (‘Type 1c’)
or above unity (‘Type 1d’) and increase with age. It should be noted
that the speciﬁc ages examined will, at least to some extent,
determine the pattern observed. For example, a male excess
reversing to female excess pattern might appear as an emerging or
increasing female excess if initial health measures were obtained at
older ages.
‘Type 2’ patterns represent either no gender difference or no
change in the gender difference with age. ‘Type 3’ represents
variations on an emergingmale excess; the patterns are the reverse
of those in Type 1. Finally, ‘Type 4’ represents any mixed or
unclassiﬁable patterns, for example an increasing then decreasing
male rate combined with a stable female rate. Due to their potential
complexity and reduced relevance from the point of this review,
‘Type 4’ patterns are not shown diagrammatically.
Aims
The current review uses systematic methods to investigate the
gender-by-age patterning of a range of physical morbidity
measures across childhood and adolescence to identify the extent
to which there is evidence of an emerging or increasing female
excess in physical morbidity over this life stage. We focus on more
general measures of physical health (self-assessed health) together
with a number of common symptoms (abdominal pain, back pain,
dizziness, sleeping problems/tiredness and headache) and condi-
tions (migraine, diabetes mellitus and epilepsy). We are aware that
distinguishing certain symptoms as ‘physical’ rather than ‘psycho-
logical’ or ‘malaise’ is necessarily somewhat arbitrary (Hunt &
Annandale, 1993). All the symptoms included in this review could
reﬂect organic (physical) disease and/or a substantial psychological
component (Pennebaker, 1982).
Our objectives, in terms of the PICOS statement (Moher, Liberati,
Tetzlaff, & Altman, 2009), were to identify, appraise and review
studies with the following characteristics:
Population: males and females aged 4e17 years;
Intervention: none
Comparator: gender and age (at least two age groups);
Outcome: gender patterning, by age, in measures of physical
morbidity;
Study design: longitudinal, cross-sectional and repeat cross-
sectional studies (including analysis of study-speciﬁc data or
routinely collected data).
Patterns of gender-by-age differences in morbidity Odds of female excess 
Type 1: Emerging or increasing female excess
1a: ‘True reversals’ – increasing female rates with age result in 
reversal from male excess to female excess 
1b: Decreasing male rates with age result in reversal from male 
excess to female excess, despite stable or even decreasing 
female rates. 
1c: No gender difference at younger ages, female excess emerges 
with age 
1d: Small female excess at younger ages, increasing with age 
OR=1 
>1 
<1 
age
age 
>1
<1 
OR=1 
>1 
<1 
age 
OR=1 
Patterns of gender-by-age differences in morbidity Odds of female excess 
Type 2: No gender difference at any age or no change in gender 
difference with age
age 
age 
age
OR=1 
OR=1 
OR=1 
>1 
>1 
>1 
<1 
<1 
<1 
Fig. 1. Patterns of gender-by-age differences in morbidity and associated odds of female excess morbidity.
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Patterns of gender-by-age differences in morbidity Odds of female excess 
Type 3: Emerging or increasing male excess
Type 4: Any mixed or unclassifiable patterns
Key:                 male morbidity rate;                female morbidity rate. 
age 
age 
OR=1 
OR=1 
>1 
>1 
<1 
<1 
OR=1 
>1 
<1 
age 
Fig. 1. (continued).
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We conducted a systematic review, whichwe have designed and
reported in line with PRISMA (Preferred Reporting Items for
Systematic Reviews and Meta-Analyses) guidelines (Moher et al.,
2009). The protocol for this review is available (Egan, MacLean,
Sweeting, & Hunt, 2012).
Data sources and search strategy
We searched ﬁve electronic databases (Medline, Embase, the
Cumulative Index to Nursing and Allied Health Literature (CINAHL),
PsycINFO, and the Education Resources Information Center (ERIC))
for studies published in English between 1992 and the date of
search (April 2010). As it was our intention to update Sweeting’s
(1995) narrative review and to focus on contemporary evidence
of gender differences in health, we aimed to identify literature
published since 1992.
We searched each database using subject headings and
keywords specifying both general health measures (Egan et al.,
2012), as well as some of the most common childhood and
adolescent self-report symptoms and chronic non-congenital/
perinatal conditions (Coleman & Schoﬁeld, 2001; Starﬁeld, 1991).
Searches were tailored to speciﬁc databases but included the
following terms: adolescent health; attitude to health; child health;
general health questionnaire; health; health attitudes; healthcomplaints; health status; health status indicators; health survey;
morbidity; self-report; symptoms; well-being; wellness; diabetes
mellitus; epilepsy; asthma; headache; headache disorders,
primary; migraine; primary headache. The full search strategies are
available in Appendices 1 and 2 of the research protocol. Although
asthma was originally included in the speciﬁc search terms, once
papers relating to asthma were extracted it became clear that
several reviews of gender differences in asthma had been con-
ducted (Almqvist et al., 2008; Postma, 2007; Zannolli & Morgese,
1997). Asthma was therefore excluded from our review to avoid
repeating this effort.
Study selection
We wanted to look at how gender differences in prevalence
(generally over past month or past year) and incidence rates (for
type 1 diabetes and epilepsy) may change with age. We included
quantitative studies which presented prevalence and incidence
data on general and speciﬁc physical morbidity measures for chil-
dren under age 18, by gender for at least two age groups. Studies
presenting data in age-bands wider than ﬁve years were excluded
because we felt such broad age-bands would make it difﬁcult to
interpret how age was associated with the (changing) gendered
patterning of health measures. Studies were excluded where we
could not distinguish between longstanding and recent illness (e.g.
included only lifetime prevalence data). We included studies that
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tions by health professionals, but excluded evidence of measures
that relied on proxy data, such as parents’ or teachers’ reports. As
a result, we excluded much of the evidence relating to babies and
toddlers (children considered too young to self-report). Studies of
those aged 18 years and over were classed as adult studies and also
excluded. Studies of young people or adults including a majority of
participants within our age-range (e.g. 15e19 years) were included.
Studies from current EU countries as well as the USA, Canada,
Australia and New Zealand were included. Studies from all other
countries were excluded on the basis that differences in wider
contextual factors (e.g. levels of development, deprivation, political
stability) may impact not only upon rates of experienced physical* 277 did not present prevalence data by sex for two age-group
39 did not present basic prevalence data. 
36 presented data by age-groups which did not meet review cr
19 were review or commentary articles. 
6 presented data on sub-populations. 
2 presented data on samples from countries we had decided to
2 presented data in relation to very small samples. 
**10 presented only parent reported data or self-report only fo
6 presented age-bands wider than 5 years. 
4 studies were excluded because there were fewer than 3 studi
7 reported only lifetime prevalence rates. 
1 reported hospitalisation rates. 
1 reported only health related quality of life. 
1 did not present basic prevalence by sex and age (and same d
Records identified by general search 
(n = 9435)
Total records identified by general and spe
(n = 12 9
Records after duplicates removed
(n = 11 2
Records retrieved in full text 
(n = 45
Records fully 
(n = 7
Records include
(n = 4
Fig. 2. Studymorbidity but also on the collection and reporting of morbidity
data which may in turn prevent useful comparisons across coun-
tries. We also excluded studies which: presented data in relation to
either males only or females only, or for both males and females for
only one age group; employed only qualitative data collection and
analysis methods; or presented data on health behaviours or
symptoms resulting from various health behaviours (e.g. muscle
pain following physical activity). Studies which presented data only
on injuries, accidents, or dental health were also excluded because
our primary interests were symptoms and conditions.
As illustrated in Fig. 2, the initial searches generated 11245 titles
(after removing duplicates). One reviewer (AM) screened all titles
and abstracts to exclude referenceswhichwere obviously irrelevants.
iteria or only included adult samples. 
 exclude. 
r one age-group.
es featuring that particular outcome. 
ata reported in another included paper).  
Records identified by specific search 
(n = 3510)
cific searches of electronic databases 
45)
/number of records screened 
45)
Records excluded through failure to 
meet inclusion criteria 
(n = 10 792)
Records for which full text was 
unable to be obtained 
(n = 1)
for detailed examination 
2)
Records excluded through failure to 
meet inclusion criteria 
(n = 381)* 
extracted 
1)
Records excluded through failure to 
meet inclusion criteria 
(n = 30)**
d in review 
1)
selection.
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aboutwhether studies shouldbe excluded, twoadditional reviewers
(KH and HS) screened the titles and abstracts and a decision was
made after discussion. Full text versions of 452 studies were ob-
tained for a second stage of screening and, after closer inspection of
each study, a further 381 failed to meet our inclusion criteria. The
remaining 71 were fully extracted of which 30 were subsequently
excluded. Thus 41 studies were deemed relevant and of sufﬁcient
scientiﬁc quality for inclusion. It should be noted that only three
studies (Santinello, Vieno, &DeVogli, 2009; Sweeting &West, 2003;
Torsheim et al., 2006) explicitly stated an intention to explore the
hypothesis that prevalence rateswould reverse frombeing higher in
males at younger ages to being higher in females in adolescence.
Data extraction
After the second screening, one reviewer (AM) extracted data
for the 71 remaining studies. Three reviewers (KH, HS and ME)
independently extracted a random sample of 10 papers each.
Although comparisons of these extraction forms generally showed
a high level of agreement between reviewers, any discrepancies
were discussed and minor changes made to seven of the sample of
30 extraction forms. The following data were extracted: (1) publi-
cation details: author; title; journal; date; primary focus; stated
aims; (2) focus on emerging/increasing female excess, deﬁned as:
mention (or not) of sex/gender differences/similarities/‘gender
reversal’ in introduction, results or discussion; explanations offered
for changes in gender differences with age; (3) study details:
methods; sample (source, size, age-range and age groups, repre-
sentativeness, response rate/completeness); primary outcomes;
questions/instruments; (4) any ﬁgures for health measures by
gender and age (e.g. prevalence rate/incidence rate, both adjusted
and unadjusted ﬁgures, extracted as reported in each paper (means,
OR, RR etc.) with as much detail as possible (95% conﬁdence
intervals, chi-square etc.)).
Critical appraisal
Many appraisal tools used in systematic reviews have been
developed to appraise randomised control trials or other study
designs used to evaluate intervention effects (although appraisal
tools for other types of study, such as case control and cohort
studies are also available (Wells et al., 2000)). To ensure our critical
appraisal was tailored to the study designs relevant to this review
(including cross-sectional studies and routine data analysis), we
adapted an existing critical appraisal tool developed for use across
a variety of study designs (Thomson, Thomas, Sellstrom, &
Petticrew, 2009). Studies were assessed against the following
potential sources of bias: sample size; multi-site design; number of
age groups presented; selection bias; outcome measurement;
analysis/data reporting, and (longitudinal studies only) attrition
rate. These are described in detail in the review protocol (Egan
et al., 2012). Studies were given an indicative score for overall
quality. This was calculated by summing the grades for each
appraisal criterion (highest grade ¼ 2; middle ¼ 1; lowest ¼ 0).
Longitudinal studies were scored out of a maximum of 14 (because
they had an extra appraisal criterion: attrition); other studies were
scored out of 12. All eligible studies were critically appraised by AM
and checked by ME, with any differences resolved by discussion.
Appraisal scores are presented in supplementary Table 1.
Data analysis
The summary measure chosen for prevalence data was the odds
ratio (OR) for a female excess and for the incidence data theincidence rate ratio (IRR), again with males as the reference group.
If these measures and their conﬁdence intervals could not be
calculated from the data within any paper, authors were
approached to provide additional data. Continuous data from
health-related quality of life scores (Solans et al., 2008) were
combined with the data on categorical self-assessed health by
reversing the scores so that high scores represented poorer health
and converting them to ORs using the method proposed by Chinn
(2000).
For a formal test of a signiﬁcant change in gender patterning
with age, we performed random effects meta-regressions of the
female excess on age. For these analyses the outcome was the
logged OR (or IRR) of a female excess; age was taken as the mean
age of the age group or the midpoint of narrow age-bands and
study weights were calculated according to the method of Der
Simonian and Laird (1986) based on the inverse variance of the
study logged OR (IRR). For longitudinal studies, the sample sizes
were divided by the number of waves in the study. The results are
presented in table form as regression coefﬁcients together with
their equivalent ORs (IRRs), and as meta-regression plots. Where
there is a signiﬁcant effect of age, the table also reports the ‘cross-
over age’, at which the female excess is estimated to begin. Where
the regression coefﬁcient is non-signiﬁcant, (i.e. the pattern of
female excess does not change with age) it is appropriate to report
the summary ORs (IRRs); we do this in the text.
In addition to the overall summaries in respect of each
morbidity measure resulting from the meta-regressions, it is
possible to infer statistically signiﬁcant age-related changes in
gender patterning within any individual study if the 95% CIs for the
ORs/IRRs for a female excess at different ages do not overlap,
although this is a somewhat conservative criterion (Cumming,
2009; Wolfe & Hanley, 2002). Odds ratios/IRRs and (with the
exception of two studies (Gordon, Dooley, & Wood, 2004;
Karvonen, Pitkaniemi, & Tuomilehto, 1999)) associated 95% CIs
were therefore also tabulated, and described in respect of which of
the ‘reversal types’ they best ﬁt (‘Type 1’ e emerging or increasing
female excess; ‘Type 2’ e no gender differences or no changes in
gender differences; ‘Type 3’ e emerging or increasing male excess;
‘Type 4’ mixed or unclassiﬁable). For the one study where ORs
could not be calculated, we present descriptive results as reported
by its authors (Rhee, Miles, Halpern, & Holditch-Davis, 2005).
All extracted data, critical appraisal scores and allocation of
physical morbidity measures to a ‘reversal type’ have been con-
ducted by one author and checked by at least one other author.
Results
Description of studies
Although the review includes 41 ‘studies’ (Fig. 2), some of these
produced multiple ﬁndings by including more than one health
outcome, and/or sampling more than one population and pre-
senting separate results by gender and age for each population. In
addition, ﬁve studies consisted of separate analysis of the multi-
national repeat cross-sectional Health Behaviour in School-aged
Children (HBSC) Survey (Cavallo et al., 2006; Haugland et al.,
2001; Meland, Haugland, & Breidablik, 2007; Santinello et al.,
2009; Torsheim et al., 2006). Three of these did not include
common data (Haugland et al. (2001) data on symptoms from
Finland, Norway, Poland and Scotland obtained in 1993e1994;
Meland et al. (2007) e data on self-assessed health from Norway
obtained in 1997e1998; and Torsheim et al. (2006) e data on
symptoms from 29 countries obtained in 1997e1998). However
two HBSC studies (Cavallo et al., 2006) (31 countries) and
(Santinello et al., 2009) (Italy only), include headache data from the
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latter are therefore included in our descriptive results, but excluded
from the meta-regression relating to headache.
The characteristics and main results of all 41 studies are
described in supplementary Table 1. Five of these studies presented
longitudinal survey data (Grimmer, Nyland, & Milanese, 2006;
Laaksonen et al., 2010; Larsson & Sund, 2005; Palacio-Vieira et al.,
2008; Sweeting & West, 2003), 26 (repeat) cross-sectional survey
data (Bigal et al., 2007; Bisegger et al., 2005; Cavallo et al., 2006;
Gadin & Hammarstrom, 2000; Gordon et al., 2004; Haugland et al.,
2001; Heinrich, Morris, & Kroner-Herwig, 2009; Holmberg &
Hellberg, 2007; Jorngarden, Wettergen, & von Essen, 2006;
Kujala, Taimela, & Viljanen, 1999; Laurell, Larsson, & Eeg-Olofsson,
2004; Leonardsson-Hellgren, Gustavsson, & Lindblad, 2001;
Lundqvist, Clench-Aas, Hofoss, & Bartonova, 2006; Mavromichalis,
Anagnostopoulos, Metaxas, & Papanastassiou, 1999; Meland et al.,
2007; Mortimer, Kay, & Jaron, 1992, 1993; Ostberg, Alfven, &
Hjern, 2006; Petersen, Bergstrom, & Brulin, 2003; Ravens-
Sieberer, Erhart, Wille, Bullinger, & Bella Study Group, 2008; Rhee
et al., 2005; Santinello et al., 2009; Sleskova, Salonna, Madarasova
Geckova, van Dijk, & Groothoff, 2005; Sundblad, Saartok, &
Engstrom, 2007; Torsheim et al., 2006; Wedderkopp, Leboeuf-
Yde, Andersen, Froberg, & Hansen, 2001), and 10 routinely
collected data (Beilmann et al., 1999; Carle et al., 2004; Casu,
Pascutto, Bernardinelli, Sardinian IDDM Epidemiology Study
Group, & Songini, 2004; Christensen et al., 2007; Cinek et al.,
2000; Cotellessa et al., 2003; Freitag, May, Pfafﬂin, Konig, &
Rating, 2001; Karvonen et al., 1999; Michalkova, Cernay, Dankova,
Rusnak, & Fandakova, 1995; Skordis et al., 2002), such as clinic/
hospital statistics.
The median critical appraisal score was 10 out of a possible 14
for longitudinal studies (range 6e12); 8 (out of a possible 12) for
(repeat) cross-sectional surveys (range 4e11); and 11 (out of 12) for
studies presenting analyses of routinely collected data (range 9e
12). These three median scores are used as benchmarks to
compare the relative quality of included studies within each type.
Thus we describe longitudinal studies, cross-sectional surveys and
routine data analysis studies scoring >10, >8 and >11 respectively
as ‘higher-scoring’. Twelve (29%) of the included studies were
consequently described as ‘higher-scoring’ (Beilmann et al., 1999;
Carle et al., 2004; Cavallo et al., 2006; Haugland et al., 2001;
Heinrich et al., 2009; Mavromichalis et al., 1999; Ostberg et al.,
2006; Petersen et al., 2003; Santinello et al., 2009; Sundblad
et al., 2007; Sweeting & West, 2003; Torsheim et al., 2006).
The results are grouped as follows: self-assessed health, symp-
toms (abdominal pain, back pain, dizziness, sleeping problems/Table 1
Results of meta-regressions testing the hypothesis of a changing female excess in each p
Physical morbidity measure B SE t
Self-assessed health 0.096 0.022 4.29
Symptoms
Abdominal pain 0.100 0.016 6.45
Back pain 0.052 0.021 2.41
Dizziness 0.083 0.028 2.97
Sleeping problems 0.067 0.014 4.72
Tiredness 0.098 0.023 4.36
Headache 0.141 0.013 10.76
Conditions
Migraine 0.093 0.022 4.27
Type 1 diabetes 0.025 0.019 1.36
Epilepsy 0.029 0.014 2.06
Note: B ¼ the coefﬁcient of age on log odds ratio (IRR); SE ¼ standard error.tiredness, headache) and conditions (migraine, type 1 diabetes,
epilepsy). For each morbidity measurewe present the results of the
meta-regressions followed by more details of individual studies.
Results in respect of the ﬁrst measure, self-assessed health, are
described in detail to facilitate comprehension of the remaining
health measures considered. These latter results are briefer and
generally restricted in the text to ‘higher-scoring’ studies (results
relating to all studies, ‘higher’ and ‘lower-scoring’, are included
within the tables). The text states when a study is ‘higher-scoring’;
any studies not identiﬁed as such are ‘lower-scoring’.
Self-assessed health
We identiﬁed three longitudinal and seven cross-sectional
studies measuring self-assessed health among males and females
across the transition from childhood to adolescence. The result of
the meta-regression testing the hypothesis of a changing female
excess in self-assessed health with age is shown in the ﬁrst row of
Table 1. The regression coefﬁcient (B) is the change in the log OR of
a female excess for one year of age. This is statistically signiﬁcant
and positive, indicating an increasing probability of poor self-
assessed health among females, relative to males, with age. The
exponentiated (anti-logged) value of the coefﬁcient is the OR, again
per year of age and this (OR ¼ 1.10) shows that the relative odds of
poor self-assessed health increase at a rate of 10% per year within
the ages included in the studies reviewed (clearly it would be
unwise to extrapolate these trends beyond the data available).
Where there is a signiﬁcant effect of age, Table 1 also shows the
estimated ‘cross-over age’, that is, the age at which the female
excess is estimated to begin. This was 7.9 years for self-assessed
health, although some caution should be exercised here as this
value lies slightly outside the range of the data (see Fig. 3).
The meta-regression plot for self-assessed health depicts
samples from named studies (Fig. 3). The size of the circles is
proportional to the study weight. As the vertical axis of the plot is
on the log scale, the value of zero corresponds to an OR of 1 (i.e. no
gender difference in rates), and a reference line is drawn at this
point. Signiﬁcant or non-signiﬁcant ORs are indicated by grey or
white circles, respectively. Grey circles above this reference line
indicate a signiﬁcant female excess, those below the line a signiﬁ-
cant male excess. The regression line shows the predicted values
from the meta-regression and the shaded area its 95% conﬁdence
band.
Further details of the 10 self-assessed health studies included in
the meta-regression are shown in Table 2. Five presented ORs (or
data allowing their calculation) of poor categorical self-assessedhysical morbidity measure with age.
p Odds ratio (95% CI) Cross-over age (years)
<0.001 1.10 (1.05e1.15) 7.9
<0.001 1.11 (1.07e1.14) 6.6
0.021 1.05 (1.01e1.10) 9.7
0.007 1.09 (1.03e1.15) 8.5
<0.001 1.07 (1.04e1.10) 10.3
<0.001 1.10 (1.06e1.15) 11.5
<0.001 1.15 (1.12e1.18) 8.7
<0.001 1.10 (1.05e1.15) 9.9
0.183 0.98 (0.94e1.01)
0.066 1.03 (1.00e1.06)
Fig. 3. Plot of meta-regression testing the hypothesis of a changing female excess in
self-assessed health with age.
Table 2
Odds (with 95% CI) of poorer self-assessed physical health among females compared
with males at each age.
Study Age OR (95% CI)
Categorical self-assessed health studies
Cavallo et al. (2006) (XS; HS)a 11 1.36 (1.29e1.43)
13 1.68 (1.60e1.76)
15 1.97 (1.88e2.06)
Holmberg and Hellberg (2007) (XS)a 13e14 1.99 (1.54e2.56)
15e16 2.51 (1.93e3.25)
17e18 2.69 (1.99e3.64)
Meland et al. (2007) (XS)a 11 1.89 (1.06e3.38)
13 2.10 (1.39e3.18)
15 1.78 (1.32e2.40)
Sleskova et al. (2005) (XS)b 15e16 1.80 (1.37e2.36)
17e18 1.82 (1.39e2.38)
Sweeting and West (2003) (L; HS)c 11 1.01 (0.86e1.18)
13 1.30 (1.10e1.53)
15 1.44 (1.22e1.71)
Physical health-related quality of life studies
Bisegger et al. (2005) (XS) d 9 1.57 (1.13e2.19)
10 1.46 (1.04e2.06)
11 1.09 (0.76e1.56)
12 1.87 (1.33e2.62)
13 2.13 (1.52e2.99)
14 2.67 (1.94e3.67)
15 3.17 (2.24e4.49)
16 3.12 (2.14e4.54)
17 3.12 (1.78e5.45)
Jorngarden et al. (2006) (XS)e 13e15 0.86 (0.40e1.83)
16e19 1.22 (0.64e2.34)
Laaksonen et al. (2010) (L)e 10 0.94 (0.74e1.18)
12 1.21 (0.96e1.53)
Palacio-Vieira et al. (2008) (L)f
Younger cohort 8e9 0.99 (0.41e2.42)
11e12 1.04 (0.44e2.51)
Older cohort 10e14 1.58 (1.00e2.50)
13e17 2.55 (1.59e4.10)
Ravens-Sieberer et al. (2008) (XS)e 11e13 1.65 (1.27e2.15)
14e17 3.19 (2.57e3.96)
XS cross-sectional study.
L longitudinal study.
HS ‘higher-scoring’ study.
a Paper includes percentages ‘poor health’ and precise Ns required for calculation
of ORs and 95% CIs.
b Paper includes percentages ‘poor health’ and sample details (percentages of
males and females and in each age group) allowing estimation of Ns required for
calculation of ORs and 95% CIs.
c Precise Ns required for calculation of ORs and 95% CIs obtained from author.
d Paper includes Ns and means; SDs obtained from author.
e Paper includes Ns, means and SDs.
f Ns, means and SDs obtained from author.
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‘higher-scoring’) show evidence of statistically signiﬁcant gender-
by-age interactions. These were a cross-sectional study (Cavallo
et al., 2006) reporting an increasing female excess of fair/poor
(vs. good/excellent) health between ages 11 (OR 1.36) and 15 (OR
1.97), and a longitudinal study (Sweeting & West, 2003) in which
the female excess of fairly/not good (vs. good) health increased
from OR of 1.01 at 11 to 1.44 at age 15. The other three cross-
sectional studies of poor categorical self-assessed health shown
on Table 2 (Holmberg & Hellberg, 2007; Meland et al., 2007;
Sleskova et al., 2005) did not ﬁnd statistically signiﬁcant gender-by-
age interactions, although the data presented by Holmberg and
Hellberg (2007) suggest an increasing female excess.
The other ﬁve self-assessed health studies reported on physical
subscale or summary scores from health-related quality of life
(HRQoL) measures. As noted above, these have been converted into
ORs to aid comparability with the categorical measures. Two of
these were longitudinal studies (Laaksonen et al., 2010; Palacio-
Vieira et al., 2008) both of which, together with one cross-
sectional study (Jorngarden et al., 2006) showed trends towards
an increasing female excess, but with overlapping CIs. The other
two cross-sectional studies reporting ‘physical’ HRQoL results
report ﬁndings that ﬁt the pattern of an emerging female excess
with non-overlapping CIs (Bisegger et al., 2005; Ravens-Sieberer
et al., 2008).
Symptoms
Abdominal pain
Twelve (one longitudinal, 11 cross-sectional) studies reported
on prevalence of abdominal pain in males and females across the
transition from childhood to adolescence. One cross-sectional
study (Haugland et al., 2001) presented separate analyses for
surveys carried out in four countries, thus 15 samples relating to
abdominal painwere available,14 of which could be included in the
meta-regression (Table 3).
The result of the meta-regression in respect of abdominal pain is
shown in Table 1 (second row) and the associated meta-regression
plot in Fig. 4. The signiﬁcant, positive regression coefﬁcient and
associated OR¼ 1.11 indicate that the probability of abdominal pain
for females, relative to males increases signiﬁcantly, and at a rate of
11% per year of age within the ages included in the reviewedstudies. The age at which the female excess in abdominal pain is
estimated to begin was 6.6 years.
Table 3, which details the individual studies, shows analyses
from three (all ‘higher-scoring’) abdominal pain studies provided
evidence of signiﬁcant ‘Type 1’ gender-by-age interactions. These
were two different HBSC surveys, conducted in around 30 European
and North American countries (Cavallo et al., 2006; Torsheim et al.,
2006) and a longitudinal study Sweeting and West (2003); each of
these studies included data from 11, 13 and 15-year olds. Findings
from the other ‘higher-scoring’ abdominal pain studies were either
suggestive of a ‘Type 1’ pattern but with overlapping 95% CIs for the
oldest and youngest age groups (Haugland et al., 2001 (Finland and
Scotland); Ostberg et al., 2006; Sundblad et al., 2007) or showed
a mixed (‘Type 4’) pattern (Haugland et al., 2001 (Poland and
Norway); Petersen et al., 2003).
Back pain
We identiﬁed one longitudinal and seven cross-sectional studies
focussing on back pain, including one with four separate country
Table 3
Odds (with 95% CI) of self-reported abdominal pain, back pain, dizziness, sleeping problems, tiredness and headache among females compared with males at each age.
Study Age Abdominal pain Back pain Dizziness Sleeping
problems
Tiredness Headache
OR (95% CI) OR (95% CI)
Cavallo et al.
(2006) (XS; HS)a
11 1.64 (1.57e1.71) 1.16 (1.10e1.22) 1.18 (1.12e1.24) 1.13 (1.09e1.17) 1.51 (1.45e1.57)
13 2.00 (1.92e2.09) 1.23 (1.18e1.29) 1.58 (1.50e1.65) 1.36 (1.31e1.41) 1.88 (1.81e1.95)
15 2.31 (2.20e2.42) 1.28 (1.23e1.34) 1.80 (1.71e1.88) 1.56 (1.50e1.62) 2.70 (2.59e2.81)
Gadin and
Hammarstrom
(2000) (XS)a
9 0.70 (0.34e1.45) 1.16 (0.70e1.95) 1.29 (0.77e2.16) 0.76 (0.39e1.48)
12 0.89 (0.39e2.04) 1.17 (0.65e2.12) 0.94 (0.57e1.54) 1.69 (0.87e3.26)
Grimmer et al.
(2006) (L)a
13 1.19 (0.59e2.40)
14 1.63 (0.83e3.20)
15 2.14 (1.16e3.97)
16 1.57 (0.82e2.99)
17 2.97 (1.31e6.71)
Haugland et al.
(2001) (XS; HS)a
Finland 11 1.63 (1.34e1.99) 0.99 (0.75e1.32) 1.34 (1.04e1.73) 1.10 (0.92e1.31) 1.69 (1.42e2.02)
13 1.75 (1.38e2.22) 1.30 (0.98e1.71) 1.64 (1.27e2.10) 1.14 (0.93e1.40) 1.96 (1.60e2.39)
15 1.84 (1.43e2.36) 1.00 (0.78e1.29) 1.42 (1.13e1.79) 1.11 (0.90e1.36) 2.81 (2.28e3.45)
Norway 11 1.66 (1.29e2.14) 1.28 (0.90e1.81) 1.45 (1.07e1.98) 1.47 (1.18e1.83) 1.94 (1.49e2.52)
13 1.48 (1.13e1.93) 1.10 (0.82e1.47) 1.43 (1.07e1.91) 1.17 (0.94e1.46) 1.30 (1.01e1.66)
15 1.78 (1.34e2.36) 1.06 (0.83e1.37) 1.53 (1.18e2.00) 1.54 (1.23e1.94) 2.19 (1.73e2.78)
Poland 11 2.31 (1.74e3.08) 3.29 (1.97e5.48) 2.13 (1.45e3.14) 1.12 (0.87e1.45) 2.53 (1.93e3.30)
13 2.94 (2.08e4.14) 1.17 (0.79e1.72) 2.56 (1.77e3.72) 1.31 (1.01e1.72) 2.15 (1.65e2.81)
15 2.33 (1.62e3.37) 1.42 (1.00e2.00) 1.78 (1.33e2.39) 1.80 (1.38e2.33) 3.04 (2.35e3.92)
Scotland 11 1.46 (1.17e1.83) 0.87 (0.62e1.22) 1.22 (0.97e1.54) 1.00 (0.83e1.20) 1.31 (1.06e1.61)
13 1.52 (1.19e1.94) 0.77 (0.57e1.04) 1.26 (0.99e1.60) 1.33 (1.07e1.66) 1.53 (1.23e1.90)
15 2.40 (1.75e3.29) 1.09 (0.80e1.49) 1.20 (0.92e1.56) 1.50 (1.20e1.89) 2.79 (2.20e3.54)
Heinrich et al. (2009)
(XS; HS)a
9e10 0.75 (0.56e0.99)
11e12 0.96 (0.72e1.28)
13e14 1.12 (0.83e1.50)
Holmberg and
Hellberg
(2007) (XS)a
13 2.86 (1.86e4.39) 2.11 (1.52e2.92)
14 3.68 (2.30e5.88) 3.06 (2.11e4.44)
15 4.08 (2.53e6.59) 4.16 (2.86e6.05)
16 1.96 (1.24e3.10) 4.66 (3.19e6.79)
17 4.68 (2.90e7.56) 4.59 (3.02e6.99)
Kujala et al. (1999)
(XS)a
10 1.13 (0.67e1.89) 0.50 (0.19e1.30) 1.38 (0.87e2.18)
14 2.50 (1.40e4.47) 1.62 (0.82e3.18) 3.38 (2.02e5.68)
16 3.32 (1.05e10.4) 1.30 (0.44e3.87) 5.00 (1.96e12.7)
Larsson and Sund
(2005) (L)a
13 2.68 (1.95e3.69)
14 3.04 (2.21e4.17)
Laurell et al.
(2004) (XS)b
7 1.10 (0.42e2.86)
8 1.16 (0.55e2.44)
9 0.81 (0.42e1.58)
10 0.97 (0.49e1.92)
11 1.45 (0.78e2.70)
12 1.95 (1.08e3.51)
13 1.46 (0.75e2.87)
14 3.33 (1.75e6.36)
15 3.77 (2.02e7.03)
Leonardsson-Hellgren
et al.
(2001) (XS)a
13e14 0.87 (0.43e1.75)
14e15 0.84 (0.32e2.17)
15e16 1.37 (0.50e3.78)
Lundqvist et al.
(2006) (XS)b
7 0.62 (0.34e1.12)
8 1.34 (0.88e2.02)
9 1.01 (0.67e1.53)
10 0.83 (0.55e1.24)
11 1.79 (1.19e2.68)
12 1.22 (0.81e1.83)
Mortimer et al.
(1993, 1992)
(XS)a
5e7 1.04 (0.54e2.01) 1.05 (0.63e1.74)
9e11 1.05 (0.40e2.71) 1.03 (0.64e1.67)
Ostberg et al. (2006)
(XS; HS)b
10 1.84 (1.28e2.65) 1.00 (0.74e1.35) 1.90 (1.32e2.73)
11 1.70 (1.17e2.49) 0.82 (0.60e1.11) 1.77 (1.25e2.50)
12 2.65 (1.78e3.93) 1.35 (0.99e1.86) 1.54 (1.09e2.18)
13 1.58 (1.07e2.31) 1.03 (0.75e1.41) 1.47 (1.05e2.06)
14 2.14 (1.35e3.39) 1.13 (0.81e1.59) 2.40 (1.67e3.46)
15 1.47 (0.95e2.28) 1.43 (1.00e2.06) 2.19 (1.52e3.14)
16 3.05 (1.91e4.86) 1.21 (0.84e1.73) 3.00 (2.05e4.38)
17 3.10 (1.83e5.24) 1.10 (0.76e1.59) 2.30 (1.55e3.41)
Petersen et al. (2003)
(XS; HS)a
6 0.53 (0.21e1.35) 2.06 (0.18e23.2) 0.72 (0.34e1.50) 0.59 (0.14e2.57)
7 1.31 (0.60e2.84) 0.38 (0.04e3.71) 0.83 (0.39e1.79) 1.19 (0.46e3.04)
8 1.36 (0.62e2.95) 0.70 (0.11e4.28) 0.67 (0.31e1.47) 1.15 (0.56e2.34)
9 2.14 (0.91e5.04) 0.87 (0.24e3.13) 0.82 (0.41e1.61) 2.30 (1.01e5.20)
10 1.55 (0.70e3.44) 0.76 (0.23e2.52) 0.99 (0.49e2.00) 1.13 (0.57e2.24)
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Table 3 (continued )
Study Age Abdominal pain Back pain Dizziness Sleeping
problems
Tiredness Headache
OR (95% CI) OR (95% CI)
11 2.03 (0.94e4.38) 0.91 (0.38e2.16) 0.97 (0.53e1.77) 1.67 (0.87e3.22)
12 1.30 (0.61e2.78) 1.95 (0.82e4.66) 1.00 (0.51e1.93) 1.38 (0.70e2.73)
Santinello et al.
(2009)
(XS; HS)a,e
11 1.23 (1.00e1.53)
13 2.15 (1.75e2.64)
15 2.91 (2.29e3.68)
Sleskova et al.
(2005) (XS)d
15e16 2.20 (1.56e3.11) 2.28 (1.39e3.73) 1.76 (1.35e2.28) 2.03 (1.50e2.74)
17e18 2.29 (1.69e3.10) 4.31 (2.47e7.53) 2.09 (1.61e2.70) 4.18 (2.98e5.86)
Sundblad et al. (2007)
(XS; HS)a
9 1.39 (0.77e2.51) 0.68 (0.42e1.11) 0.37 (0.19e0.73) 1.47 (0.80e2.69)
12 1.90 (0.99e3.63) 0.98 (0.59e1.64) 1.23 (0.75e2.01) 2.28 (1.42e3.66)
15 2.70 (1.42e5.10) 1.83 (1.12e2.99) 1.25 (0.89e1.76) 2.87 (1.82e4.52)
Sweeting and West
(2003) (L; HS)b
11 1.48 (1.26e1.74) 0.82 (0.67e1.00) 0.89 (0.76e1.04) 1.49 (1.28e1.75)
13 2.07 (1.74e2.47) 1.25 (1.04e1.50) 1.14 (0.96e1.35) 1.48 (1.25e1.76)
15 3.15 (2.62e3.80) 1.68 (1.40e2.02) 1.69 (1.42e2.01) 2.41 (1.98e2.92)
Torsheim et al.
(2006) (XS; HS)c
11 1.86 (1.69e2.05) 1.25 (1.14e1.37) 1.41 (1.26e1.58) 1.11 (1.04e1.18) 1.58 (1.46e1.71)
13 2.29 (2.02e2.59) 1.29 (1.19e1.40) 1.83 (1.62e2.06) 1.36 (1.26e1.47) 2.01 (1.84e2.19)
15 2.67 (2.33e3.06) 1.34 (1.22e1.47) 1.79 (1.59e2.01) 1.57 (1.46e1.69) 2.90 (2.64e3.18)
Wedderkopp
et al. (2001)
(XS)a
8e10 0.34 (0.13e0.90)
14e16 1.22 (0.70e2.11)
Rhee et al. (2005)
(XS)f
11e21 Female excess
at all ages
Female excess at
all ages
Female excess
increased signiﬁcantly
with age
Female excess
increased
signiﬁcantly with
age
XS cross-sectional study.
L longitudinal study.
HS ‘higher-scoring’ study.
a Paper includes percentages with symptom and precise Ns required for calculation of ORs and 95% CIs.
b Precise Ns required for calculation of ORs and 95% CIs obtained from author.
c Paper includes ORs and 95% CIs of symptom among females compared with males.
d Paper includes percentages ‘poor health’ and sample details (percentages of males and females and in each age group) allowing estimation of Ns required for calculation of
ORs and 95% CIs.
e Excluded from meta-analysis (data included in Cavallo et al., 2006).
f Descriptive results from text of paper; further data unavailable; excluded from meta-analyses.
A. MacLean et al. / Social Science & Medicine 78 (2013) 96e112 105analyses (Table 3). While ﬁve of these studies measured ‘back pain’
generally (Cavallo et al., 2006; Haugland et al., 2001; Petersen et al.,
2003; Sleskova et al., 2005; Torsheim et al., 2006), three measured
‘low back pain’ (Grimmer et al., 2006; Kujala et al., 1999;
Wedderkopp et al., 2001).
The result of the meta-regression (Table 1, third row) and
associated meta-regression plot (Fig. 4) indicates that the proba-
bility of back pain for females, relative to males increases signiﬁ-
cantly, at a rate of 5% per year of age within the ages included in the
reviewed studies. The age at which the female excess in back pain is
estimated to begin was 9.7 years.
Seven back pain analyses were from ‘higher-scoring’ studies
(Table 3). One of these (Cavallo et al., 2006) provided evidence of
statistically signiﬁcant ‘Type 1’ gender-by-age interactions, another
(Torsheim et al., 2006) was suggestive of the ‘Type 1’ pattern and
three showed a ‘Type 4’ (mixed) pattern (Haugland et al., 2001
(results for Finland and Scotland); Petersen et al., 2003). Finally,
two analyses reported by Haugland et al. (2001), suggested ‘Type 3’
(emerging male excess) patterns, with decreasing odds of a female
excess in back pain between ages 11 and 15 in Norway and Poland,
but both with overlapping CIs.
Dizziness
The meta-regression results from eight samples with data
relating to dizziness (Table 1) and associated meta-regression plot
(Fig. 4) indicates that the probability of a female excess in dizziness
increases signiﬁcantly and at a rate of 9% per year of age within the
ages included in the reviewed studies. The female excess in dizzi-
ness is estimated to begin at 8.5 years.
Table 3 summarises results from nine analyses of dizziness
(from six studies). Four of these studies were ‘higher-scoring’. Ofthese, three (Cavallo et al., 2006; Sweeting &West, 2003; Torsheim
et al., 2006) showed signiﬁcantly increasing ORs of self-reported
dizziness amongst females compared with males between ages
11 and 15. However, the fourth (Haugland et al., 2001) provided no
evidence of signiﬁcant gender-by-age interactions in any of its four
country-speciﬁc analyses.
Sleeping problems/tiredness
Table 3 reports ten analyses relating to sleeping problems and
ﬁve relating to tiredness.
The meta-regression results (Table 1) and associated meta-
regression plots (Fig. 4) indicate that the probabilities for females,
relative to males increase signiﬁcantly, at a rate of 7% (sleeping
problems) and 10% (tiredness) per year of age, within the ages
included in the reviewed studies. The female excess in these
symptoms is estimated to begin at 10.3 years for sleeping problems
and 11.5 years for tiredness.
Of the 15 separate analyses, 11 were from ‘higher-scoring’
studies. Six of these provided statistically signiﬁcant evidence of
a ‘Type 1’ pattern, ﬁve in respect of sleeping problems (Cavallo
et al., 2006; Haugland et al., 2001 (Scotland results); Sundblad
et al., 2007; Sweeting & West, 2003; Torsheim et al., 2006) and
one in respect of tiredness (Sundblad et al., 2007). None of the other
‘higher-scoring’ sleeping problems/tiredness analyses showed
signiﬁcant changes in gender differences with age.
Headache
We identiﬁed two longitudinal and 17 cross-sectional studies
measuring prevalence of headache (22 sets of analyses in total -
Table 3). Themeta-regression results (Table 1) and associatedmeta-
regression plot (Fig. 4) indicate that out of all the included physical
Fig. 4. Plot of meta-regression testing the hypothesis of a changing female excess in
symptoms (abdominal pain, back pain, dizziness, sleeping problems, tiredness, head-
ache) with age.
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shows the steepest increase with age (15% per year of age within
the ages included in the reviewed studies). The female excess in
headache is estimated to begin at 8.7 years.
Twelve of the individual headache analyses came from ‘higher-
scoring’ studies (Table 3), of which six provided statistically
signiﬁcant evidence of a ‘Type 1’ pattern (Cavallo et al., 2006;
Haugland et al., 2001 (Finland and Scotland results respectively);
Santinello et al., 2009; Sweeting & West, 2003; Torsheim et al.,2006). Of the remaining analyses from ‘higher-scoring’ studies,
two showed ‘Type 1’ trends (Heinrich et al., 2009; Sundblad et al.,
2007) and four a mixed (‘Type 4’) pattern (Haugland et al., 2001
(Norway and Poland); Ostberg et al., 2006; Petersen et al., 2003).
Conditions
Migraine
We identiﬁed ﬁve studies measuring prevalence of migraine
(self-reported according to internationally recognised criteria). The
meta-regression (Table 1, Fig. 5) indicated that the probability of
migraine among females, relative to males, increases signiﬁcantly,
and at a rate of 10% per year of age within the ages included in the
reviewed studies, and that the female excess in migraine is esti-
mated to begin at 9.9 years.
Table 4 details the individual migraine studies, two of which
were ‘higher-scoring’. One of these showed trends towards a ‘Type
1’ pattern in past year migraine to 1988 IHS criteria (Mavromichalis
et al., 1999, higher scoring). In the other, therewas little evidence of
gender differences in past six months migraine (2004 IHS criteria)
at any age (Heinrich et al., 2009).
Type 1 diabetes
Seven studies reporting incidence of Type 1 diabetes were
identiﬁed, all based on routine data. Since one (Carle et al., 2004)
presented ﬁndings for data from four separate Italian regions, the
diabetes studies comprise ten separate sets of ﬁndings. The meta-
regression (Table 1, Fig. 5) indicated no increase with age in the
probability of diabetes incidence among females, relative to males.
Indeed, there was a non-signiﬁcant trend in the opposite direction
(i.e. an increasing probability of diabetes incidence among males,
relative to females, with age e a ‘Type 3’ pattern) within the ages
included in the reviewed studies. Since the non-signiﬁcant
regression coefﬁcient indicates no change with age in the pattern
of female excess, it is appropriate to report the summary IRR (95%
CI). This was 0.87 (0.79e0.97), indicating excess incidence of dia-
betes among males within the age groups included in the studies
reviewed here.
Table 5, which details the individual diabetes studies, shows
that in no sample did the female excess in incidence differ signif-
icantly between age groups. However, six of the ten analyses
showed trends towards an increasing or emerging male excess of
diabetes incidence with age, including all four samples from the
only ‘higher-scoring’ diabetes study (Carle et al., 2004; Casu et al.,
2004; Karvonen et al., 1999).
Epilepsy
In relation to epilepsy incidence, we identiﬁed three studies, all
based on routine data (Table 5). Themeta-regression (Table 1, Fig. 5)
indicated a non-signiﬁcant increase with age in the probability of
epilepsy incidence among females, relative to males. The summary
IRR (95% CI), which it is therefore appropriate to report, was 0.98
(0.86e1.11), indicating no clear gender difference in epilepsy inci-
dence within the age groups included in the studies reviewed here.
This result is based on a small number of studies, only one of
which was ‘higher-scoring’. Table 5 which details the epilepsy
studies, shows that the female:male IRR in the higher scoring study
(Beilmann et al., 1999) showed trends towards an emerging male
excess. However, analysis of a much larger sample (Christensen
et al., 2007) showed a trend towards an emerging female excess.
Sensitivity analysis
A sensitivity analysis was conducted to assess the impact of
including only one wave from each of the longitudinal studies. The
Fig. 4. (continued).
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longitudinal studies in turn. Headache and self-assessed health
had data frommore than one longitudinal study and in those cases
all possible combinations of waves were generated (6 for headache
and 24 for self-assessed health). The coefﬁcients from these
repeated analyses were then averaged. The resulting values were
little changed e the largest differences being for dizziness(B ¼ 0.074); self-assessed health (B ¼ 0.086) and sleep problems
(B ¼ 0.063).
Discussion
Past research and systematic reviews of psychological morbidity
and asthma have reported robust evidence that higher male
Fig. 5. Plot of meta-regression testing the hypothesis of a changing female excess in conditions (migraine, type 1 diabetes, epilepsy) with age.
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higher prevalence among adolescent females (Almqvist et al., 2008;
Bennett et al., 2005; Cohen et al., 1993; Cyranowski et al., 2000; Ge
et al., 2001; Hankin & Abramson, 1999; Marcotte et al., 2002;
Nicolai et al., 2003; Nolen-Hoeksema & Girgus,1994; Petersen et al.,
1991; Postma, 2007; Schraedley et al., 1999; Sears et al., 2003;
Shibley Hyde et al., 2008; Venn et al., 1998; Zannolli & Morgese,1997). For example, two reviews of gender and age differences in
asthma prevalence and incidence during childhood and adoles-
cence reported that asthma is more common in males before age
ten and in females by the mid-teen years (Almqvist et al., 2008;
Zannolli & Morgese, 1997). Studies have also reported this pattern
for other forms of physical morbidity (Eiser, Havermans, & Eiser,
1995; Eminson et al., 1996; Haugland et al., 2001; Hetland,
Table 4
Odds (with 95% CI) of migraine among females compared with males at each age.
Study Ages OR (95% CI)
Bigal et al. (2007) (XS)b 12 0.93 (0.66e1.32)
13 1.23 (0.89e1.70)
14 1.16 (0.86e1.57)
15 1.57 (1.17e2.10)
16 2.22 (1.62e3.05)
17 2.56 (1.95e3.35)
Gordon et al. (2004) (XS)c 12e14 1.67
15e19 2.45
Heinrich et al. (2009) (XS; HS)a 9e10 1.12 (0.77e1.61)
11e12 0.93 (0.68e1.29)
13e14 1.13 (0.84e1.53)
Laurell et al. (2004) (XS)d 7e9 0.70 (0.30e1.64)
10e12 1.50 (0.86e2.62)
13e15 1.48 (0.89e2.45)
Mavromichalis et al. (1999) (XS; HS)a 4e6 0.54 (0.13e2.18)
7e9 1.03 (0.63e1.66)
10e12 1.68 (1.10e2.56)
13e15 2.00 (1.00e3.98)
XS cross-sectional study.
HS ‘higher-scoring’ study.
a Paper includes percentages with migraine and precise Ns required for calcula-
tion of ORs and 95% CIs.
b Paper includes percentages with migraine and sample details (percentages of
males and females an in each age group) allowing estimation of Ns required for
calculation of ORs and 95% CIs.
c Paper includes percentages; Ns required for calculation of 95% CIs unavailable.
d Paper includes percentages; Ns obtained from author.
Table 5
Incidence rate ratios (with 95% CIs) of diabetes and epilepsy among females
compared with males at each age.
Study Ages Diabetes Epilepsy
IRR (95% CI) IRR (95% CI)
Carle et al. (2004) (RD; HS)a
Northern Italy 5e9 0.84 (0.63e1.12)
10e14 0.76 (0.58e1.00)
Central Italy 5e9 0.95 (0.78e1.16)
10e14 0.86 (0.71e1.05)
Southern Italy 5e9 1.21 (0.95e1.54)
10e14 0.76 (0.59e0.98)
Sardegna 5e9 0.79 (0.64e0.98)
10e14 0.61 (0.50e0.75)
Casu et al. (2004) (RD)b 4 0.83 (0.49e1.42)
5 0.94 (0.58e1.53)
6 1.02 (0.67e1.57)
7 0.49 (0.32e0.77)
8 0.56 (0.35e0.90)
9 0.87 (0.60e1.25)
10 0.66 (0.45e0.96)
11 0.84 (0.57e1.24)
12 0.36 (0.24e0.55)
13 0.55 (0.37e0.81)
14 0.49 (0.31e0.77)
Cinek et al. (2000) (RD)b 4 0.94 (0.62e1.43)
5 1.23 (0.83e1.82)
6 0.96 (0.65e1.40)
7 0.89 (0.61e1.29)
8 1.21 (0.83e1.74)
9 1.40 (1.00e1.97)
10 1.42 (1.02e1.96)
11 1.29 (0.93e1.78)
12 1.33 (0.98e1.80)
13 0.72 (0.53e0.98)
14 0.89 (0.65e1.23)
Cotellessa et al. (2003) (RD)a 5e9 0.60 (0.36e1.01)
10e14 0.73 (0.47e1.13)
Karvonen et al. (1999) (RD)c 5e9 0.98
10e14 0.82
Michalkova et al. (1995) (RD)d 5e9 1.15 (0.63e2.07)
10e14 1.69 (0.91e3.16)
Skordis et al. (2002) (RD)b 5e6 0.60 (0.26e1.37)
7e8 1.17 (0.54e2.52)
9e10 1.60 (0.84e3.05)
11e12 1.33 (0.68e2.60)
13e14 0.73 (0.34e1.60)
Beilmann et al. (1999) (RD, HS)a 5e9 1.40 (0.78e2.51)
10e14 0.70 (0.38e1.28)
15e19 0.80 (0.22e2.92)
Christensen et al. (2007) (RD)b 4e5 0.85 (0.75e0.97)
6e7 0.81 (0.72e0.92)
8e9 0.78 (0.69e0.89)
10e11 0.97 (0.85e1.12)
12e13 1.09 (0.93e1.27)
14e15 1.27 (1.09e1.47)
16e17 1.15 (0.99e1.34)
Freitag et al. (2001) (RD)e 5e9 2.33 (0.60e9.03)
10e14 0.83 (0.25e2.73)
RD study based on routinely collected data.
HS ‘higher-scoring’ study.
a Paper includes IRRs and 95% CIs of condition among females compared with
males.
b Precise Ns required for calculation of IRRs and 95% CIs obtained from author.
c Paper includes incidence rates; Ns required for calculation of 95% CIs
unavailable.
d Paper includes incidence Ns and rates, allowing calculation of Ns required for
calculation of 95% CIs.
e Paper includes graphed incidence rates and total population at risk, which when
split in males and females allowed calculation of Ns required for calculation of 95%
CIs.
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Sweeting & West, 2003; Torsheim et al., 2006). However, this
systematic review is the ﬁrst to investigate gender-by-age
patterning of a range of physical morbidity measures across
childhood and adolescence in order to assess how strong the
evidence is of a generalised or condition/symptom-speciﬁc
emerging or increasing female excess in physical morbidity over
this life stage.
Our descriptive results and meta-regressions provided statis-
tically robust evidence of an emerging or increasing female excess
in eight of the 10 physical morbidity measures examined. Prior to
conducting our analyses, and in order to help ourselves concep-
tualise gender-by-age differences in morbidity, we proposed
a series of plausible patterns, and our results can be summarised
in these terms. A ‘Type 1’ pattern (emerging/increasing female
excess) was particularly strong in relation to self-report measures
such as self-assessed health and various symptoms, especially
headache and abdominal pain. This ‘Type 1’ pattern was also
evident in relation to migraine (self-reported but requiring use of
recognised diagnostic criteria). In contrast, this pattern was far
less robust in relation to epilepsy and there was strongest
evidence of an emerging or increasing male excess (‘Type 3’) in
relation to type 1 diabetes, both of which were assessed via
medical professionals’ reports. Thus, gender-by-age differences in
measures of physical morbidity varied by both study design and
measure.
The proposed ‘Type 1’ patterns were further differentiated in
respect of whether the odds of morbidity among females
compared to males would start from below, at or above unity,
while noting that the speciﬁc ages examined will, at least to some
extent, determine the pattern observed. While we began with the
assumption that, if evident at all, a gender ‘reversal’ was likely to
occur in adolescence, the evidence presented here suggests that it
occurs at earlier ages in most cases. Among the measures for which
there was evidence of a signiﬁcant increase in the female excess
with age, the ‘cross-over age’ was between 6 and 8 years for
four health measures (abdominal pain, poor self-assessed health,dizziness and headache) and between 9 and 11 for another four
(back pain, migraine, sleeping problems and tiredness).
Research to date suggests that both biological factors, including
differing effects of puberty on boys’ and girls’ health, and social
A. MacLean et al. / Social Science & Medicine 78 (2013) 96e112110inﬂuences, such as the impact of societal gender- and age-related
expectations on experiences and reporting of illness, may
contribute to gender-by-age patterns in morbidity during the
transition from childhood to adolescence (Angold et al., 1999;
Haugland et al., 2001; Lien, Dalgard, Heyerdahl, & Bjertness, 2006;
Sweeting & West, 2003; Sweeting et al., 2007). There are a number
of implications from this review for our understandings of the
observed patterns. Firstly, evidence that a female excess was more
robust for some measures of physical morbidity than others
suggests symptom- or condition-speciﬁc explanations and points
us towards trying to identify potential mechanisms driving
gender-by-age variations in symptom/condition prevalence.
Secondly, most ‘reversals’ were estimated to occur prior to the ages
at which we would expect puberty to occur, suggesting that this
factor might be less important than generally assumed, although
some studies (e.g. de Munick Keizer-Schrama & Mul, 2001) report
that age at puberty is declining. Thirdly, a female excess was more
robust for self-report physical morbidity measures, rather than
those based on clinical diagnoses which may have been informed
or validated via diagnostic tests. Although self- or other-reporting
of symptoms/conditions and medical decisions precede such tests,
this ﬁnding might be because the ‘gender reversal’ is an artefact of
the research methods used, a reﬂection of greater physical
morbidity in females, or a result of under-reporting in males as
they get older. Nevertheless, in the absence of self-reported
measures of diabetes and epilepsy, and without routine data on
consultation rates for a range of symptoms, this hypothesis cannot
be further tested.
This review has a number of strengths. First, it was designed and
reported based on the PRISMA checklist (Moher et al., 2009).
Second, the focus is novel; despite calls for systematic reviewers to
widen their focus beyond intervention evaluations, there are rela-
tively few published systematic reviews of epidemiological and
other non-intervention studies (Egan, Tannahill, Petticrew, &
Thomas, 2008). Third, two search strategies (general and speciﬁc)
were used across multiple databases to ensure that our search for
articles was sufﬁciently wide yet also adequately sensitive, with the
two sets of terms largely identifying different evidence (Egan et al.,
2012). Fourth, the data reviewed spanned the transition from early
childhood to early-mid adolescence. Fifth, rigorous and systematic
methods were used to identify and synthesize the evidence,
including checks by at least two reviewers of all extracted data and
critical appraisal scores. Sixth, meta-regressions were conducted in
order to speciﬁcally test the hypothesis of a changing female excess
with age in respect of each of the ten morbidity measures. The fact
that ‘Type 1 reversals’ were evident, despite the fact that the vast
majority of studies included in our review were not speciﬁcally
designed to examine this issue and so less likely to be subject to
publication bias in this respect, is an additional strength. Related to
this, although individual datasets may have been underpowered for
detection of gender-by-age interactions (since gender ‘reversals’
was not their aim), the strength of a meta-analysis is that study
results are combined, thus eliminating the problem of underpow-
ered datasets. In addition, we have found that the hypothesised
relative increase in female morbidity tends to be supported by the
more robust evidence we identiﬁed. Over two thirds (70.2%) of
ﬁndings from higher scoring studies suggested a Type 1 relation-
ship, of which a third were statistically signiﬁcant (although higher
scoring studies of type 1 diabetes and epilepsy showed non-
signiﬁcant type 3 patterns).
Some limitations should also be highlighted. As with all
systematic reviews, there is the potential for publication bias, even
if not in respect of gender ‘reversals’, and the studies we accessed
were limited to those which were available through the databases
we searched. We speciﬁcally excluded studies from countries otherthan the EU, the USA, Canada, Australia and New Zealand, which
means our conclusions cannot be extended beyond these coun-
tries; ﬁndings might differ in, for example, Muslim or Asian
countries. Similarly, given that gendered behaviours, including
those relating to health, are constrained by what is deemed
socially acceptable for boys/girls, men/women within a cultural
context at a speciﬁc time (Connell, 2012), ﬁndings might have
differed had we examined older, rather than more contemporary
datasets. Our appraisal of the methodological quality of included
studies is subject to limitations common to checklist approaches to
appraising systematic reviews (Juni, Witschi, Bloch, & Egger, 1999).
Furthermore, attempts to appraise study quality are reliant on
good reporting of study methods. A further issue is that a large
proportion of the evidence for an emerging or increasing female
excess came from a small number of large-scale ‘higher-scoring’
studies in which there were statistically signiﬁcant gender-by-age
interactions across (almost) all their self-reported physical
morbidity measures (Cavallo et al., 2006; Sweeting & West, 2003;
Torsheim et al., 2006).Conclusion
For the physical morbidity measures that we reviewed, the
balance of evidence broadly pointed towards an emerging or
increasing female excess during the transition from childhood to
adolescence. Evidence of this pattern was strongest in relation to
headache, abdominal pain, tiredness, migraine and self-assessed
health, whereas some (although not statistically signiﬁcant)
evidence of an emerging/increasing male excess was found in
relation to type 1 diabetes.
Evidence that identiﬁes the age at which gender differentials
emerge or increase is important for informing strategies and
interventions that aim to prevent or reduce gender inequalities in
health. This review provides evidence to suggest that researchers,
public health practitioners and policy-makers should recognise
mid-late childhood rather than adolescence as a key life stage
during which gender inequalities (notably female excess
morbidity) emerge. However, our ﬁndings also suggest that gender-
by-age interactions during this life stage are outcome-speciﬁc. To
further understandings of the aetiology of gender differences in
health, this review highlights a need for good quality longitudinal
research which spans childhood and adolescence, i.e. beginning
before age 11 which is frequently the youngest age included in such
studies, and explores the outcome-speciﬁcity of these patterns.Acknowledgements
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